NYSE Euronext (NYX) today announced trading volumes for its global derivatives and cash equities exchanges for February 20101. Derivatives trading volumes in February 2010 recorded strong year-over-year growth, with European derivatives volumes increasing 44.2% and U.S. options trading volumes increasing 56.4%. Cash equities trading volumes were mixed in February 2010, with European cash transactions increasing 9.1% and U.S. cash equities trading volumes declining 35.7% from prior year elevated levels. Both European and U.S. cash trading volumes, however, remain above fourth quarter 2009 levels.

Highlights

• NYSE Euronext European derivatives products average daily volume (“ADV”) in February 2010 of 4.9 million contracts increased 44.2% compared to February 2009, but decreased 3.3% from January 2010 levels. Total European fixed income products ADV in February 2010 of 2.8 million contracts increased 50.3% compared to February 2009 and increased 1.4% from January 2010. Fixed income product ADV is at the highest level since January of 2008. Total equity products ADV of 2.1 million contracts in February 2010 increased 37.8% compared to February 2009, but decreased 9.1% from January 2010.
• NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 3.4 million contracts in February 2010 increased 56.4% compared to February 2009 levels, but decreased 19.7% from January 2010. NYSE Euronext’s U.S. options exchanges accounted for 26.9% of the total consolidated equity options trading in February 2010, up from 17.3% in February 2009, but down from 27.8% in January 2010. NYSE Euronext was the largest U.S. equity options exchange group in the industry in February 2010.
• NYSE Euronext European cash products ADV of 1.4 million transactions in February 2010 increased 9.1% compared to February 2009 and increased 4.1% from January 2010.
• NYSE Euronext (NYSE, NYSE Arca and NYSE Amex) U.S. cash products handled ADV of 2.6 billion shares in February 2010 decreased 35.7% compared to February 2009 and decreased 3.7% compared to January 2010. NYSE Euronext matched share of all U.S. cash equity trading volume was 27.7% in February 2010, up from 26.5% in January 2010. NYSE Euronext’s Tape A matched market share in February 2010 was 36.6%, up from 34.3% in January 2010.
• There were a total of 20 trading days in Europe and 19 trading days in the U.S. in February 2010 and February 2009.

Derivatives Trading

European Derivatives

• NYSE Euronext European derivatives products ADV in February 2010 was 4.9 million futures and options contracts, an increase of 44.2% from February 2009, but a decrease of 3.3% from January 2010. The 4.9 million in futures and options contracts ADV in February 2010 consisted of 3.9 million contracts executed through our full-service LIFFE CONNECT trading platform and 1.0 million contracts, or 20.7%, executed through Bclear, NYSE Liffe's trade administration and clearing service for OTC products. Year-to-date, European derivatives products ADV of 5.0 million contracts was 37.7% above prior year levels. The 5.0 million in futures and options contracts ADV year-to-date consisted of 4.0 million contracts executed through LIFFE CONNECT trading platform and 1.0 million contracts, or 20.8%, executed through Bclear.
• Total fixed income products ADV of 2.8 million contracts in February 2010 increased 50.3% from February 2009 and increased 1.4% from January 2010. Fixed income product ADV is at the highest level since January of 2008. Year-to-date, total fixed income products ADV of 2.8 million contracts was 43.7% above prior year levels.
• Total equity products (including Bclear) ADV of 2.1 million contracts in February 2010 increased 37.8% compared to February 2009, but decreased 9.1% from January 2010. The 2.1 million contracts in equity products ADV consisted of 1.5 million contracts in individual equity products ADV and 0.6 million contracts in equity index products ADV. The 1.5 million contracts in individual equity products ADV consisted of 0.8 million in futures contracts, which represented a 175.2% increase compared to February 2009 and 0.7 million in options contracts, which represented a 7.5% increase compared to February 2009. Year-to-date, total equity products ADV of 2.2 million contracts was 31.6% above prior year levels.

U.S. Derivatives

• NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 3.4 million contracts in February 2010 increased 56.4% compared to February 2009, but decreased 19.7% compared to January 2010. Year-to-date, U.S. equity options ADV of 3.8 million contracts was 79.1% above prior year levels.
• Total U.S. consolidated equity options ADV increased 0.4% to 12.6 million contracts in February 2010 compared to February 2009, but decreased 17.0% compared to January 2010. Year-to-date, U.S. consolidated equity options ADV of 13.9 million contracts was 13.5% above prior year levels.
• NYSE Euronext’s U.S. options exchanges accounted for 26.9% of the total consolidated equity options trading in February 2010, up from 17.3% in February 2009. NYSE Euronext was the largest U.S. equity options exchange group in February 2010 for the second consecutive month.
• NYSE Euronext U.S. futures and futures options (NYSE Liffe U.S.) ADV in February 2010 was approximately 23,000 contracts, compared to 22,000 contracts in January 2010. Year-to-date U.S. futures and futures options ADV was 22,000 contracts.

Cash Trading

European Cash

• NYSE Euronext European cash products ADV of 1.4 million transactions in February 2010 increased 9.1%, compared to February 2009 and increased 4.1% compared to January 2010. European cash estimated market share in terms of value traded was relatively stable. Year-to-date, European cash products ADV of 1.4 million transactions was 6.6% above prior year levels.

U.S. Cash

• NYSE Euronext U.S. cash products handled ADV in February 2010 decreased 35.7% to 2.6 billion shares compared to February 2009 and decreased 3.7% from January 2010. Year-to-date, U.S. cash products handled ADV was 2.7 billion shares, down 30.0% from prior year levels.
• NYSE Euronext’s Tape A matched market share in February 2010 was 36.6%, up from 34.3% in January 2010.
• Designated Market Maker participation in February 2010 was 8.5%, compared to 8.8% in January 2010. Supplemental Liquidity Provider participation in February 2010 was 12.1%, compared to 11.1% in January 2010. DMM and SLP participation pertain only to trading on NYSE.

Exchange Traded Products

• NYSE Euronext U.S. matched exchange-traded products ADV (included in volumes for Tape B and Tape C) of 364 million shares in February 2010 decreased 41.9% compared to February 2009, but increased 4.9% compared to January 2010. Year-to-date, NYSE Euronext U.S. matched exchange-traded products ADV of 356 million shares was 38.7% below prior year levels.

Please click here for the Monthly Transaction Activity Data Table.

About NYSE Euronext

NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With more than 3,700 listed operating companies, NYSE Euronext's equities markets – the New York Stock Exchange, NYSE Euronext, NYSE Amex, NYSE Alternext and NYSE Arca – represent one-third of the world's equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, one of the leading European derivatives businesses and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index, and is the only exchange operator in the S&P 100 index and Fortune 500. For more information, please visit: http://www.nyx.com.

Cautionary Note Regarding Forward-Looking Statements

This press release may contain forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning NYSE Euronext’s plans, objectives, expectations and intentions and other statements that are not historical or current facts. Forward-looking statements are based on NYSE Euronext’s current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause NYSE Euronext’s results to differ materially from current expectations include, but are not limited to: NYSE Euronext’s ability to implement its strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk and U.S. and global competition, and other factors detailed in NYSE Euronext’s reference document for 2008 ("document de référence") filed with the French Autorité des Marchés Financiers (Registered on April 28, 2009 under No. R. 09-031), 2009 Annual Report on Form 10-K and other periodic reports filed with the U.S. Securities and Exchange Commission or the French Autorité des Marchés Financiers. In addition, these statements are based on a number of assumptions that are subject to change. Accordingly, actual results may be materially higher or lower than those projected. The inclusion of such projections herein should not be regarded as a representation by NYSE Euronext that the projections will prove to be correct. This press release speaks only as of this date. NYSE Euronext disclaims any duty to update the information herein.

1 All NYSE Euronext derivatives transactions count buy and sell orders together as a single transaction. NYSE Euronext European equities transactions count each buy and sell order as separate transactions, NYSE Euronext U.S. equities transactions count buy and sell orders together as a single transaction.